Case Study: Leading Pharma Company cuts application sprawl and costs with Persistent Systems

Leading Pharma company identifies over 2000 redundant apps and tremendous cost-saving initiatives

Leading Pharma Company, one of the world’s largest pharmaceutical companies, was struggling with application sprawl created over years of mergers, acquisitions, and upgrades. With more than 6,000 applications across multiple business units, the company lacked a single view of its IT portfolio, which drove higher management costs, reduced ROI, added complexity, and raised security concerns.

Persistent Systems used its SURE framework and APR tool, along with a systematic top-down rationalization approach, to assess the client’s application landscape by integrating data from CMDBs, service requests, and user surveys. Persistent Systems evaluated 8,513 applications and identified 2,000 redundant applications for elimination and 1,122 critical applications for upgrade, helping align the portfolio to a leaner, growth-focused digital strategy.